- Home
- RNAC vs QIPT Comparison
RNAC vs QIPT Comparison
Compare RNAC & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | QIPT |
|---|---|---|
| Founded | 2007 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.1M | 161.9M |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RNAC | QIPT |
|---|---|---|
| Price | $8.15 | $3.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $35.00 | $3.83 |
| AVG Volume (30 Days) | 176.5K | ★ 318.2K |
| Earning Date | 06-15-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,797,000.00 | ★ $245,359,000.00 |
| Revenue This Year | N/A | $28.30 |
| Revenue Next Year | $26.02 | $1.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.98 | $1.37 |
| 52 Week High | $17.42 | $3.65 |
Technical Indicators
Market Signals| Indicator | RNAC | QIPT |
|---|---|---|
| Relative Strength Index (RSI) | 56.95 | 71.77 |
| Support Level | $6.41 | $3.55 |
| Resistance Level | $10.49 | N/A |
| Average True Range (ATR) | 0.82 | 0.02 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 62.82 | 90.00 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.